5104 C-terminal domain in DHH phosphoesterases
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 9 | 5.5 | 1.65× | q = 0.12 | |
| Homogeneous metal compounds | 12 | 9.7 | 1.24× | q = 0.45 | |
| Homogeneous non-metal compounds | 7 | 4.2 | 1.65× | not tested | |
| Organic oxygen compounds | 1 | 3.9 | 0.26× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00131 | AMP | Adenosine phosphate | 15 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 3 |
| DB00160 | — | Alanine | 2 |
| DB01812 | A3P | Adenosine 3',5'-diphosphate | 2 |
| DB02431 | CTP | Cytidine-5'-Triphosphate | 2 |
| DB00171 | ATP | ATP | 1 |
| DB01643 | TMP | Thymidine monophosphate | 1 |
| DB03403 | C5P | Cytidine-5'-Monophosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| AMP | ADENOSINE MONOPHOSPHATE | 12 |
| 2PN | IMIDODIPHOSPHORIC ACID | 8 |
| MGmetal | MAGNESIUM ION | 8 |
| CL | CHLORIDE ION | 6 |
| MNmetal | MANGANESE (II) ION | 6 |
| CAmetal | CALCIUM ION | 4 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 3 |
| 2BA | (2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9-bis(6-amino-9H-purin-9-yl)octahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-3,5,10,12-tetrol 5,12-dioxide | 2 |
| A3P | ADENOSINE-3'-5'-DIPHOSPHATE | 2 |
| C2E | 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) | 2 |
| CTP | CYTIDINE-5'-TRIPHOSPHATE | 2 |
| IOD | IODIDE ION | 2 |
| IY0 | [5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3,4-bis(oxidanyl)furan-2-yl]methyl dihydrogen phosphate | 2 |
| IY9 | [5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3-oxidanyl-furan-2-yl]methyl dihydrogen phosphate | 2 |
| A1JDM | [(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-fluoranyl-2-(phosphonooxymethyl)oxolan-3-yl]oxy-[2-[(2~{R},3~{S},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-oxolan-2-yl]ethenyl]phosphinic acid | 1 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 1 |
| C5P | CYTIDINE-5'-MONOPHOSPHATE | 1 |
| IXK | [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)furan-3-yl] [5-(6-aminopurin-9-yl)-3-oxidanyl-furan-2-yl]methyl hydrogen phosphate | 1 |
| TMP | THYMIDINE-5'-PHOSPHATE | 1 |
| ZNmetal | ZINC ION | 1 |